Amolbika HCT Tablet 5/20/12.5mg

Adult dose

This medication should be taken once daily, with or without food, using water. It is recommended to take it at the same time each day (e.g., in the morning). The recommended dosing is as follows: - 5/20/12.5mg: for patients whose blood pressure is inadequately controlled with Amlodipine/Olmesartan medoxomil 5/20mg combination therapy. - 5/40/12.5mg: for patients whose blood pressure is inadequately controlled with Amlodipine/Olmesartan medoxomil 5/40mg.

Child dose

Safety and efficacy in pediatric patients under 18 years have not been established, so use of this medication is not recommended.

This medication can cause serious harm to the fetus and newborn if taken during the second and third trimesters of pregnancy, so it should be discontinued immediately upon confirmation of pregnancy. Patients who are allergic to any of the ingredients or similar medications, pregnant or nursing women, and patients with severe hypotension or heart valve diseases should not take this medication. Patients with decreased blood volume or impaired kidney function require special caution when starting this medication, as symptoms of hypotension may occur and their condition should be closely monitored. Patients with poor kidney or liver function, those with specific heart diseases, or electrolyte imbalances should be particularly careful when taking this medication and require regular testing. Since this medication lowers blood pressure, symptoms such as dizziness or drowsiness may occur, so caution is needed when driving or operating machinery. During treatment, electrolyte levels and kidney function should be monitored frequently through blood tests, and if any unusual symptoms arise, immediate consultation with a doctor is necessary. This medication may interact with other drugs, so inform your doctor or pharmacist about any other medications you are taking. If you are nursing, discuss with your doctor whether to continue or cease breastfeeding, as the components of this medication may pass into breast milk. The safety and efficacy of this medication in children under 18 years have not been established, so its use is not recommended. In the case of overdose, severe hypotension and heart issues may occur, so strict adherence to the dosage is essential and seek medical attention immediately if side effects appear. Store this medication away from direct sunlight and moisture in a place out of reach of children, and it is advisable not to transfer it to another container.

Serious side effects

Hives, severe swelling (edema), chest tightness, difficulty breathing, cold sweat, pallor, severe rash with fever, blisters, peeling skin, pain in oral/ocular mucosa, difficulty or shortness of breath, asthma attacks, cough with fever-related respiratory issues, yellowing of the skin or eyes (jaundice), extreme fatigue, sudden and severe headaches, lightning-like headaches, seizures, confusion, vision changes, paralysis, urination changes

Mild side effects

• Peripheral edema
• headache
• dizziness
• upper respiratory infection
• nasopharyngitis
• urinary tract infection
• sialadenitis
• leukopenia
• thrombocytopenia
• bone marrow suppression

This medication may be sensitive to air and moisture, so it must be stored in a tightly sealed container. The recommended storage temperature is room temperature between 1 degree and 30 degrees Celsius.

Appearance

White and orange round film-coated tablet

Package unit

30 tablets/box [(10 tablets/Alu-Alu x 3)]